Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

95 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A novel reduced-intensity umbilical cord blood transplantation using a recombinant G-CSF combined with high-dose Ara-C for active myeloid malignancies.
Gotoh M, Yoshizawa S, Katagiri S, Suguro T, Asano M, Kitahara T, Akahane D, Okabe S, Tauchi T, Ito Y, Ohyashiki K. Gotoh M, et al. Among authors: suguro t. Bone Marrow Transplant. 2014 Jul;49(7):955-60. doi: 10.1038/bmt.2014.66. Epub 2014 Apr 14. Bone Marrow Transplant. 2014. PMID: 24732960 Clinical Trial.
[Treatment-free molecular remission achieved by combination therapy with imatinib and IFNα in CML with BIM deletion polymorphism relapsed after stop imatinib].
Katagiri S, Tauchi T, Umezu T, Saito Y, Suguro T, Asano M, Yoshizawa S, Kitahara T, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Ito Y, Ohyashiki JH, Ohyashiki K. Katagiri S, et al. Among authors: suguro t. Rinsho Ketsueki. 2015 Feb;56(2):216-9. doi: 10.11406/rinketsu.56.216. Rinsho Ketsueki. 2015. PMID: 25765803 Japanese.
BIM deletion polymorphism accounts for lack of favorable outcome in Japanese females with follicular lymphoma.
Ito Y, Umezu T, Tadokoro K, Saito Y, Katagiri S, Suguro T, Asano M, Yoshizawa S, Akahane D, Tanaka Y, Fujimoto H, Okabe S, Gotoh M, Tauchi T, Kawana C, Ohyashiki JH, Nakamura N, Ohyashiki K. Ito Y, et al. Among authors: suguro t. Leuk Lymphoma. 2019 May;60(5):1283-1288. doi: 10.1080/10428194.2018.1529310. Epub 2018 Nov 27. Leuk Lymphoma. 2019. PMID: 30480474
Maintenance 5-azacytidine therapy by MRD monitoring after allogeneic HSCT in myeloid/lymphoid neoplasms with FGFR1 rearrangement.
Katagiri S, Umezu T, Azuma K, Kobayashi C, Akahane D, Suguro T, Furuya N, Fujimoto H, Nakamura N, Ohyashiki JH, Ohyashiki K. Katagiri S, et al. Among authors: suguro t. Bone Marrow Transplant. 2019 Jul;54(7):1148-1150. doi: 10.1038/s41409-019-0436-1. Epub 2019 Jan 22. Bone Marrow Transplant. 2019. PMID: 30670826 No abstract available.
Downregulation of extracellular vesicle microRNA-101 derived from bone marrow mesenchymal stromal cells in myelodysplastic syndrome with disease progression.
Saitoh Y, Umezu T, Imanishi S, Asano M, Yoshizawa S, Katagiri S, Suguro T, Fujimoto H, Akahane D, Kobayashi-Kawana C, Ohyashiki JH, Ohyashiki K. Saitoh Y, et al. Among authors: suguro t. Oncol Lett. 2020 Mar;19(3):2053-2061. doi: 10.3892/ol.2020.11282. Epub 2020 Jan 9. Oncol Lett. 2020. PMID: 32194702 Free PMC article.
95 results